OvaScience (OVAS) Co-Founder David Sinclair, Ph.D., Selected By TIME As One Of The 100 Most Influential People In The World
4/24/2014 9:52:47 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today announced that the Company’s scientific Co-Founder, David Sinclair, Ph.D., has been selected for the 2014 TIME 100, TIME’s annual list of the 100 most influential people in the world. Dr. Sinclair’s extensive research on aging and the key role of mitochondria (the energy source for all cells) contributed to OvaScience’s foundational egg precursor cell (EggPCSM) technology platform. The Company expects to launch its first fertility product, AUGMENTSM, in international in vitro fertilization (IVF) clinics in 2014. AUGMENT is designed to improve egg quality and the success of IVF by enhancing mitochondrial function.
Help employers find you! Check out all the jobs and post your resume.
comments powered by